Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Aerobic Dance Exercises in Fibromyalgia Syndrome

15 de mayo de 2026 actualizado por: Tugba Civi Karaaslan, Istanbul University

The Effectiveness of Aerobic Dance Exercises in Fibromyalgia Syndrome: A Randomized Controlled Trial

The aim of this study was to evaluate the effects of aerobic dance exercises on patients with Fibromyalgia syndrome (FMS) and to compare these effects with those of conventional postural exercises.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Descripción detallada

The aim of this study was to evaluate the effects of aerobic dance exercises on patients with Fibromyalgia syndrome (FMS) and to compare these effects with those of conventional postural exercises. A total of 44 female participants were included. Group-1 (n=22) received aerobic dance exercises twice a week for eight weeks, while Group-2 (n=22) was given a conventional postural exercise program as a home-based intervention with the same duration and frequency. To evaluate the participants, the following assessment tools were used: Fibromyalgia Impact Questionnaire, McGill-Melzack Pain Questionnaire, Short Form-36, Pittsburgh Sleep Quality Index, Beck Depression Inventory, International Physical Activity Questionnaire-Short Form, and Fatigue Severity Scale. Both groups showed significant improvements in nearly all parameters after the intervention (p<0.05).

Tipo de estudio

Intervencionista

Inscripción (Actual)

44

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • diagnosis of FMS according to the American College of Rheumatology (ACR) diagnostic criteria
  • being female between the ages of 18 and 65
  • having the physical capacity to exercise

Exclusion Criteria:

  • unstable angina pectoris with severe dyspnea that would prevent exercise
  • the presence of any neurological or orthopedic disease other than FMS

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Aerobic Dance Exercises
The aerobic protocol for Group-1 was divided into four distinct phases: warm-up, endurance training, stretching, and cooling down. These sessions were led by a physiotherapist in groups of five, using music to guide the exercise rhythm. Initial warm-ups lasted 5 to 7 minutes and involved stationary marching and stepping patterns. A 20-minute core segment followed, featuring group dance movements that incorporated various torso and limb rotations. Cardiovascular challenge was integrated through 5 minutes of rapid-paced dance. The program ended with a 5-minute cool-down period where participants gradually reduced their activity level in alignment with a slowing musical tempo.
Otro: Aerobic Dance Exercises
The aerobic protocol for Group-1 was divided into four distinct phases: warm-up, endurance training, stretching, and cooling down. These sessions were led by a physiotherapist in groups of five, using music to guide the exercise rhythm. Initial warm-ups lasted 5 to 7 minutes and involved stationary marching and stepping patterns. A 20-minute core segment followed, featuring group dance movements that incorporated various torso and limb rotations. Cardiovascular challenge was integrated through 5 minutes of rapid-paced dance. The program ended with a 5-minute cool-down period where participants gradually reduced their activity level in alignment with a slowing musical tempo.
Experimental: Conventional Exercises
To improve muscle balance and protect spinal integrity, Group-2 performed conventional posture exercises targeting the neck, back, core, and shoulders. This routine, a common clinical approach for individuals with FMS, was conducted as a home-based program with a frequency of two sessions per week. To ensure compliance and track progress, each participant utilized a dedicated exercise diary to record their activities throughout the study.
Otro: Conventional Exercises
To improve muscle balance and protect spinal integrity, Group-2 performed conventional posture exercises targeting the neck, back, core, and shoulders. This routine, a common clinical approach for individuals with FMS, was conducted as a home-based program with a frequency of two sessions per week. To ensure compliance and track progress, each participant utilized a dedicated exercise diary to record their activities throughout the study.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Fibromyalgia Impact Scale
Periodo de tiempo: change from baseline at 8 weeks
To measure the impact of the disease on daily life, a 20-question assessment tool was utilized, focusing on domains such as physical capacity, occupational health, and psychological well-being. Additionally, the scale screens for pain intensity, stiffness, sleep quality, and overall vitality. The scoring system is structured such that higher results indicate more pronounced symptoms and lower functional capacity, while lower scores reflect better health status. Total scores range from 0 to 100, with higher scores indicating greater disease impact and poorer functional status.
change from baseline at 8 weeks
McGill-Melzack Pain Scale
Periodo de tiempo: change from baseline at 8 weeks
To characterize the nature and intensity of the pain, the McGill-Melzack scale was utilized. This assessment encompasses a detailed analysis of pain topography, its sensory qualities, and duration. It also accounts for specific triggers or modifiers of pain frequency. Scoring is interpreted such that higher cumulative values reflect more profound pain symptoms and increased clinical severity.Total scores range from 0 to 78, with higher scores indicating greater pain severity and pain-related distress
change from baseline at 8 weeks

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Short Form-36 Health Survey (SF-36)
Periodo de tiempo: change from baseline at 8 weeks
The Short Form-36 Health Survey is a comprehensive 36-item questionnaire used to assess health-related quality of life, including physical functioning, psychosocial functioning, pain, and mental health status. Each subscale is scored on a scale ranging from 0 to 100, with higher scores indicating better functional status and improved overall health-related quality of life.
change from baseline at 8 weeks
Pittsburgh Sleep Quality Index
Periodo de tiempo: change from baseline at 8 weeks
The PSQI was utilized to measure participants' self-reported sleep quality and related disturbances. The scale comprises 19 items that form seven sub-scores, which are then aggregated into a single global score between 0 and 21. While lower scores are indicative of better sleep quality, a cumulative score higher than five is clinically interpreted as a sign of significant sleep dysfunction.
change from baseline at 8 weeks
Beck Depression Inventory
Periodo de tiempo: change from baseline at 8 weeks
To evaluate participants' depressive states, the BDI, which consists of 21 questions, was utilized. Each item is scored between 0 and 3, and the total score is used to determine the intensity of the symptoms. Clinical classifications were made based on the total score: 0-9 points as no depression, 10-16 points as mild, 17-23 points as moderate, and any value 24 or above as severe depression.
change from baseline at 8 weeks
International Physical Activity Questionnaire-Short Form
Periodo de tiempo: change from baseline at 8 weeks
The International Physical Activity Questionnaire-Short Form will be used to assess participants' physical activity levels. The questionnaire evaluates the frequency and duration of walking, moderate-intensity activity, vigorous-intensity activity, and sedentary behavior over the last 7 days. Total physical activity is calculated in metabolic equivalent (MET)-minutes/week. Higher scores indicate higher levels of physical activity.
change from baseline at 8 weeks
Fatigue Severity Scale
Periodo de tiempo: change from baseline at 8 weeks
To evaluate the impact of fatigue, the FSS, which views fatigue severity as a single-dimensional construct, was administered. Participants responded to nine statements using a scoring range from 1 to 7. The overall fatigue score was derived from the average of these ratings; consequently, an increase in the total score indicates a greater level of perceived fatigue.
change from baseline at 8 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Istanbul University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

6 de mayo de 2022

Finalización primaria (Actual)

6 de enero de 2023

Finalización del estudio (Actual)

6 de mayo de 2023

Fechas de registro del estudio

Enviado por primera vez

5 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

15 de mayo de 2026

Publicado por primera vez (Actual)

18 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

18 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

15 de mayo de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Palabras clave

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • IstanbulUC4

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir